Retinal and Preretinal Hemorrhages in a Patient Receiving Hyper-CVAD Chemotherapy for T-Cell Acute Lymphoblastic Leukemia
Hyperfractionated cyclophosphamide, vincristine, adriamycin, and dexamethasone (Hyper-CVAD) is an important chemotherapeutic regimen for acute lymphoblastic leukemia (ALL) and non-Hodgkin’s lymphoma. We present a case of a 23-year-old male with T-cell ALL and visual acuity of 20/20 in the right eye...
Saved in:
Main Authors: | Krishi Peddada, Stephanie J. Weiss, Shaina Kumar, Deepika Malik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/9457549 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Factors and Outcome of Patients with Adult Acute Lymphoblastic Leukemia Treated with the Hyper-CVAD Regimen: A Retrospective Study
by: Zahra Malakoutikhah, et al.
Published: (2023-01-01) -
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
by: Marlise R. Luskin, et al.
Published: (2025-02-01) -
Acute Lymphoblastic Leukemia Presenting Initially as Spinal Cord Compression: When Chemotherapy Alone Is Enough
by: Albert Jang, et al.
Published: (2020-01-01) -
Osteoporosis in Acute Lymphoblastic Leukemia
by: Lestry Fibriani, et al.
Published: (2019-09-01) -
Recurrent Gastrointestinal Hemorrhage in Children with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with Dasatinib: Case Reports
by: Xin Liao, et al.
Published: (2020-01-01)